Correspondence 0001493152-23-034425 from Syra Health Corp (SYRA) (CIK 0001922335) (SYRA)

Syra Health Corp (SYRA) (CIK 0001922335)
Date: Sept. 27, 2023 · CIK: 0001922335 · Accession: 0001493152-23-034425

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-271622

Date

Sept. 27, 2023

Author

Chief

Form

CORRESP

Company

Syra Health Corp (SYRA) (CIK 0001922335)

Letter

SYRA HEALTH CORP.

Keystone Way N. #201

Carmel, IN 46032

September 27, 2023

VIA EDGAR

United States Securities and Exchange Commission

F. Street, NE

Washington, DC 20549

Attn: Scott Stringer

Joel Parker

Brian Fetterolf

Erin Jaskot

Re: Syra Health Corp.

Registration Statement on Form S-1, as amended

File No. 333-271622

Ladies and Gentlemen:

Syra Health Corp. (the “Company”) hereby respectfully withdraws its request, dated September 22, 2023, that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, September 26, 2023. The Company intends to submit a revised acceleration request at a later date.

Please contact Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 if there are any questions with respect to this request.

Thank you,

SYRA HEALTH CORP.

By:

/s/ Deepika Vuppalanchi

Name:

Deepika Vuppalanchi

Title:

Chief Executive Officer

Show Raw Text

CORRESP
1
filename1.htm

SYRA
HEALTH CORP.

1119
Keystone Way N. #201

Carmel,
IN 46032

September
27, 2023

VIA
EDGAR

United
States Securities and Exchange Commission

100
F. Street, NE

Washington,
DC 20549

    Attn:
    Scott Stringer

    Joel Parker

    Brian Fetterolf

    Erin Jaskot

  Re:
  Syra Health Corp.

  Registration Statement on Form S-1, as amended

  File No. 333-271622

Ladies
and Gentlemen:

Syra
Health Corp. (the “Company”) hereby respectfully withdraws its request, dated September 22, 2023, that the effective date
of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday,
September 26, 2023. The Company intends to submit a revised acceleration request at a later date.

Please
contact Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 if there are any questions
with respect to this request.

    Thank you,

    SYRA
    HEALTH CORP.

    By:

    /s/
    Deepika Vuppalanchi

    Name:

    Deepika
    Vuppalanchi

    Title:

    Chief
    Executive Officer

SecProbe.io